Viewing Study NCT02007005

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:20 AM
Ignite Modification Date: 2026-02-28 @ 8:18 AM
Study NCT ID: NCT02007005
Status: COMPLETED
Last Update Posted: 2015-05-06
First Post: 2013-12-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer
Sponsor: Abnoba Gmbh
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Superficial Bladder Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None superficial bladder cancer View
None mistletoe extract View
None maximum tolerated dose View
None marker tumor View
None remission View
None recurrence rate View